Close Research Gaps With Japanese RWD

Register Free: https://www.pharmexec.com/pe_w/research_goals

Event Overview:
Valuable information for insight generation can be gleaned from health data, however gaining access to the right real-world data to answer questions is critical for effective study design. The use of RWD in Europe and North America is well-established, yet there’s now a strong demand from the global research community to leverage Japanese patient data to advance scientific discoveries and to offer new treatment opportunities to patients with unmet needs.

IQVIA provides analytical insights and access to a global RWD network covering more than 1 billion non-identified patients and through the E360™ platform. Medical Data Vision (MDV) data (one of the largest real-world longitudinal databases in Japan, with 40+ million patients from 460+ hospitals) is now integrated into the E360™.

Researchers can gain a comprehensive view of a patient’s hospital health care history by using the unique MDV data that includes de-identified claims, procedures, medications, and lab data, to help understand treatment patterns, clinical development, market access, and evidence generation.

What you will learn:

Join this webinar to learn more about the unique value of the MDV database and how you can leverage it for your research studies in an increasingly global world.

See first-hand how the MDV database allows you to:

• Easily explore Japanese data and reach insights faster through a demo of the E360™ self-service analytics platform
• Track the trends of the current Japanese pharmaceutical market and tailor your brand strategy in real time
• Seamlessly connect a patient’s steps along their health care journey, helping you to assess the market strategically and maximize your bran
• Efficiently run cross-country comparisons and analysis by using MDV converted to an internationally adopted common data format (OMOP).
  

Speakers

Shujiro Takeno
Manager
IQVIA Solutions Japan

Shujiro Takeno has 10+ years of pharmaceutical industry experience and 5+ years of Real World Data (RWD) analytics and Global RWD leadership experience. He has been involved in numerous projects using RWD such as Oncology and Immunology disease markets. He also leads the development and promotion of RWD analytic tool, E360™ in Japan.

Philippe Auvaro
EBM Overseas Business - Executive Director
Medical Data Vision Co., Ltd.

Philippe Auvaro is responsible for MDV data business development overseas. Prior to MDV, Philippe was President of OrphanPacific, Inc., leading a joint venture group (between CMIC Group and MEDIPAL) specialized in rare diseases. Prior to CMIC Group, he established and was President of Aspen Pharmacare and spent 25 years holding various senior management positions at companies including GlaxoSmithKline, Aventis, Handok Pharmaceuticals, and Roussel in various countries in the Asia-Pacific region.

Alan Thomas
Senior Director
IQVIA Solutions Japan

Alan Thomas brings over 20 years experience in healthcare consulting and services, 9 of which as head of the IQVIA Japan, Japan thought leadership team. He works with multiple stakeholders within healthcare, delivering data-driven intelligence and decision support including clinical and commercial insights, dynamics within the Japan and global markets, and impact of policy and trends on the future outlook of healthcare.

Register Free: https://www.pharmexec.com/pe_w/research_goals